BioHealth Innovation
If you are having trouble viewing this email, please click here

June 18, 2019


Rich Bendis Presentation at NCI and FNL Technology Showcase


Read More

Inaugural BIO Health Caucus - A Success!

On behalf of AURP, and our BIO Health Caucus Co-Chairs Mark Romney and Rich Bendis, we would like to thank all who participated at the inaugural BIO Health Caucus, making it a grand success!

Each of our speakers and sessions shared significant insight into what is on the horizon for our global biomedical innovation district. Everyone's active presence was paramount in our ongoing mission to help the AURP community thrive. This gathering of bio-focused professionals served as an opportunity to establish, promote, and assemble health-related anchor institutions, creating new technologies, developing biotechnology partnerships, and improving health outcomes.

The next BIO Health Caucus will converge at the AURP IC2019 on November 5, 1:00 – 4:00 pm.

Read More

The Top 10 Highest-Paid Women Executives in Biopharma - Martine Rothblatt, Chairman of United Therapeutics #2

After last year’s BIO International Convention in Boston was overshadowed by reports of topless women dancers bearing the logos of biopharma company sponsors at an unofficial party, the Biotechnology Innovation Organization in October sent its members a letter insisting that they pay more than lip service to diversifying their historically male executive suites and boardrooms.

Read More

RoosterBio Receives Grant from Maryland Stem Cell Research Fund to Commercialize MSC-EV Technology

RoosterBio, a regenerative medicine manufacturing technology leader, has received a $300,000 grant from the Maryland Stem Cell Research Commission to facilitate new product development. RoosterBio is one of three Maryland-based companies who received the Maryland Stem Cell Research Fund (MSCRF) Commercialization Program Award totaling $899,990 to assist with the creation of start-up companies or new technologies developed in Maryland.

Read More

Think Solutions: Qiagen - MCEDC Success Stories

MCEDC talks with Douglas Liu, SVP of Global Operations for Qiagen, about how his company makes improvements in life possible.

Read More

How to Woo Capitol Hill? Johns Hopkins Is Putting On a Research Extravaganza - The Chronicle of Higher Education

Hundreds of politicians, Capitol staff members, and campus top brass will gather on Wednesday in Washington to hear about researchers’ work. The scholars aren’t leaving any detail to chance.

Read More

Andrew Lees, Ph.D., Fina Biosolutions, LLC - 2019 Johns Hopkins Alumni Award Winner

Andrew Lees, Ph.D., is founder and scientific director of Fina Biosolutions, LLC (Rockville, Md.), a company focused on promoting affordable conjugate vaccines by making the technology available to emerging market vaccine manufacturers. Among his contributions in the field, Lees developed an efficient linking chemistry which is widely used in conjugate vaccines, a class that includes vaccines for S. pneumoniae and meningococcal disease. The chemistry has helped to reduce the cost of these vaccines.

Read More

REGENXBIO Announces First FDA Approval of a Gene Therapy Based on Its Proprietary NAV® Technology Platform

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced the first U.S. Food and Drug Administration (FDA) approval of a gene therapy that leverages REGENXBIO's proprietary NAV Technology Platform, Novartis AG's ZOLGENSMA® (onasemnogene abeparvovec-xioi; AVXS-101). ZOLGENSMA was approved by the FDA as a one-time infusion for pediatric patients with spinal muscular atrophy (SMA) who are less than two years of age.

Read More

Bayh-Dole Rocks While the Critics Play the Same False Note

A just-released study co-sponsored by the Biotechnology Innovation Organization (BIO) and AUTM provides new evidence of the significant contribution academic patent licensing makes to the U.S. economy. The report is the most recent in a series, and the numbers are astounding.

Read More

Five Companies That Are Changing the Landscape for Cell and Gene Therapy · BioBuzz

Gene therapies represent some of the most promising advancements in science and human health in recent history.  The BioHealth Capital Region, and Maryland in particular, is rapidly becoming a hub for companies in this field. With the NIH and the National Cancer Institute at the nucleus, some of the most advanced scientific research and technology development in the field is happening in a short 30-mile radius around Montgomery County, Maryland.

Read More

70 Years of Scientific Research on Diseases

70 Years of Scientific Research on Diseases (1947-2017) - number of research articles published (PubMed) # For more interesting & helpful content on healthcare & data science, follow me & Brainformatika on LinkedIn.

Read More

Corvidia Therapeutics Initiates Phase 2b Dose-Finding Study for Ziltivekimab | Business Wire

Corvidia Therapeutics Inc., a clinical stage biotechnology company, announced today the initiation of patient screening for a Phase 2b dose-finding study of ziltivekimab. Previously known as COR-001, ziltivekimab is a proprietary anti-interleukin-6 ligand monoclonal antibody (anti-IL6 mAb), targeting residual inflammatory cardiovascular risk in patients living with advanced chronic kidney disease (CKD).

Read More

Frederick research centers look to advance technology through partnerships | Treatment And Diseases |

A vaccine for HIV. Nanoparticles. A topical ointment for sickle cell disease.

Those are just three examples of technologies discussed at a showcase held by the Frederick National Laboratory for Cancer Research and the National Cancer Institute.

Read More

Alexandria Real Estate Equities, Inc. Announces Strategic Partnership With Columbia University to Open Alexandria LaunchLabs @ Columbia, Deepening Its Focus on Cutting-Edge Life Science Companies Spinning Out of NYC's Renowned Academic Institutions

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT uniquely focused on collaborative life science and technology campuses in AAA innovation cluster locations, today announced that it has strategically partnered with Columbia University to open Alexandria LaunchLabs®, the premier life science startup platform, at the university in the spring of 2020. Building upon the success of the flagship Alexandria LaunchLabs site at the Alexandria Center® for Life Science – New York City, Alexandria LaunchLabs @ Columbia will increasingly focus on promising life science startups emerging from Columbia and peer institutions, which serve as the greatest source of new company formation in the NYC life science ecosystem.

Read More

Women in healthcare | McKinsey

How does the healthcare sector stack up on gender equality? To answer that question, we look at pipeline practices, employee experiences, and policies and programs the industry has implemented to promote diversity and inclusion. We also hear from industry leaders on what it takes to accelerate change across the sector.

Read More

Lunch and Learn: Accessing the Virginia Neuroscience Initiative (VNI)

Wednesday, June 26, 2019 from 11:45 AM to 1:00 PM EDT

Attendees will be provided an overview of Virginia Neuroscience (VNI) Initiative and how it accelerates neuroscience research by providing strategy, infrastructure, and research tools to clinicians, researchers, and industry. VNI members conduct basic and translational research in neurobiology to advance our understanding of brain diseases.

Read More

Drop Anywhere Labs Launch Event RSVP

You are invited to join Learning Undefeated as we expand our reach again and welcome three new mobile laboratories.

Drop Anywhere Labs are the newest innovation in mobile STEM education, custom-built shipping containers that serve as flexible laboratory and classroom space for middle and high schools. Tour all six of our mobile laboratories including Drop Anywhere Labs, the Mobile eXploration Lab, MdBioLab, and Verizon explorer lab.

Event Info

Date: Thursday, August 1, 2019

Time: 4:00 - 6:00 PM

Read More

D.C.'s Top Economic Development Official Leaving To Join Amazon

D.C.'s top economic development official is leaving government to join Amazon as the tech giant builds its second headquarters in Northern Virginia.

Deputy Mayor for Planning and Economic Development Brian Kenner, who has held the position for over four years, will join Amazon to tackle regional economic development issues, the Washington Business Journal reports.

Read More

Women Building Bio 2019 - Virginia Bio

Inova Center for Personalized Health, Fairfax You’re invited to spend the day with innovative entrepreneurs, professionals and industry leaders. Discover opportunities to help you navigate through a rapidly evolving modern industry & gain access to cutting edge technologies and tools.

Join forces with industry and academia leaders, researchers and decision-makers, all gathered together, at the same time, and at the same place, bringing ideas together to make a global impact and change the world.

Women Building Bio is where the future is transformed into reality.

Read More

Concept to Clinic: Commercializing Innovation (C3i) Program | National Institute of Biomedical Imaging and Bioengineering

The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). Through this program, the NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The curriculum and customized mentoring provided by the C3i Program are intended to guide investigators as they assess the commercial viability and potential business opportunity for their innovation.

Read More

Alexandria, Verily Bring Opioid Treatment Campus to Dayton - Connect Media Commercial Real Estate News

The first facility has opened at Dayton, OH’s 4.3-acre OneFifteen campus, a treatment center for opioid addiction. The project is a partnership of life sciences REIT Alexandria Real Estate Equities and Verily, an Alphabet company, with Alexandria leading design and development.

Read More

Home | About BHI | BHI News | Programs | Partners | Contact

Copyright © BioHealth Innovation 2017
All Rights Reserved.